CIENCIASMEDICASNEWS: Letter Revoking Emergency Use Authorization (EUA) of Chloroquine Phosphates Supplied from the Strategic National Stockpile for Treatment of COVID-19 in Certain Hospitalized Patients

miércoles, 17 de junio de 2020

Letter Revoking Emergency Use Authorization (EUA) of Chloroquine Phosphates Supplied from the Strategic National Stockpile for Treatment of COVID-19 in Certain Hospitalized Patients | NLM

Disaster Information Management Research Center | NLM

Disaster Information and Emergency Response

Letter Revoking Emergency Use Authorization (EUA) of Chloroquine Phosphates Supplied from the Strategic National Stockpile for Treatment of COVID-19 in Certain Hospitalized Patients

06/15/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 6/15/2020. This 15-page document provides a memorandum explaining the basis for revocation of the Emergency Use Authorization for Emergency Use of Chloroquine Phosphate and Hydroxychloroquine Sulfate, effective June 15, 2020. (PDF)